Details for 2011164516

Up to date per 02.04.2026

Actions

Title / Product Name

Kombination des HMG-CoA -Reduktase-Inhibitors Rosuvastatin mit einem Phosphodiesterase-4-Inhibitor, wie z.B Roflumilast, Roflumilast-N-Oxide, zur Behandlung von entzündlichen Lungenerkrankungen

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011164516

EP Publication Number

2359826

E-Number

638246

Language

PCT Number

Publication Date

24.08.2011 A

30.10.2013 B1

Registration Date

30.10.2013

AT Publication Date

15.11.2013

Application Date

03.07.2007

Registration Number

Priorities

05.07.2006

06116625

IPC

A61K 31/44 20060101AFI20130415BHEP

Maximum Duration of Protection

03.07.2027

Owner

AstraZeneca AB151 85 SödertäljeSE

Representative

Sonn & Partner PatentanwälteRiemergasse 141010 Wien

Inventor

Wollin, Stefan-Lutz Mälzergasse 3 88339, Bad WaldseeDE

Wohlsen, Andrea Steubenring 6 53175, BonnDE

Braun, Clemens Sepp-Biehler-Str. 3 78464, KonstanzDE

Marx, Degenhard Obere Reute 15 78345, MoosDE